Argon and diode laser photocoagulation in proliferative diabetic retinopathy: A preliminary report

R. Brancato, F. Bandello, G. Trabucchi, G. Leoni, R. Lattanzio

Research output: Contribution to journalArticle

Abstract

Twenty-six eyes of 24 diabetic patients affected by proliferative diabetic retinopathy were randomly treated with diode (810 nm) (13 eyes) and argon-green (514 nm) lasers (13 eyes). In the diode laser group, partial or total regression of neovascularizations was observed in 9 eyes (69.2%) while 4 (30.8%) remained unchanged. In argon-green group seven eyes (53.8%) showed partial or total regression, 5 (38.2%) unchanged and 1 (7.6%) worsened. The mean follow-up time was 6.8 months (SD 2.2) for the diode laser group and 7.8 months (SD 3.2) for the argon-green laser group. The authors discuss the results and the clinical side-effects observed on the basis to the further development of the diode laser in clinical practice.

Original languageEnglish
Pages (from-to)233-237
Number of pages5
JournalLasers and Light in Ophthalmology
Volume3
Issue number3
Publication statusPublished - 1990

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Argon and diode laser photocoagulation in proliferative diabetic retinopathy: A preliminary report'. Together they form a unique fingerprint.

  • Cite this